Beurs gesloten -
Nasdaq
22:30:01 14-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
9,05
USD
|
-1,09%
|
|
+13,84%
|
+25,69%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
84,26
|
90,28
|
66,06
|
75,58
|
47,96
|
33,08
|
Bedrijfswaarde
1 |
76,09
|
82,36
|
57,87
|
67,41
|
41,48
|
23,98
|
K/w-verhouding
|
19,4
x
|
19
x
|
20
x
|
16,2
x
|
18,7
x
|
12,8
x
|
Dividendrendement
|
5,73%
|
5,6%
|
5,42%
|
6,87%
|
6,51%
|
4,86%
|
Marktkapitalisatie/omzet
|
6,12
x
|
6,64
x
|
6,01
x
|
5,43
x
|
3,78
x
|
3,04
x
|
Bedrijfswaarde/omzet
|
5,53
x
|
6,06
x
|
5,27
x
|
4,84
x
|
3,27
x
|
2,2
x
|
Bedrijfswaarde/EBITDA
|
13,2
x
|
14,8
x
|
15,2
x
|
11,6
x
|
9,94
x
|
8,08
x
|
Bedrijfswaarde/FCF
|
22,1
x
|
25,2
x
|
19
x
|
16,3
x
|
26,8
x
|
10,8
x
|
FCF Yield
|
4,52%
|
3,98%
|
5,28%
|
6,14%
|
3,74%
|
9,25%
|
Price to Book
|
7,71
x
|
8,49
x
|
6,38
x
|
7,7
x
|
5,18
x
|
2,9
x
|
Aantal aandelen (in duizenden)
|
4.594
|
4.594
|
4.594
|
4.594
|
4.594
|
4.594
|
Referentieprijs
2 |
18,34
|
19,65
|
14,38
|
16,45
|
10,44
|
7,200
|
Datum van publicatie
|
21/03/19
|
26/03/20
|
22/03/21
|
23/03/22
|
23/03/23
|
22/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
13,77
|
13,6
|
10,99
|
13,93
|
12,7
|
10,89
|
EBITDA
1 |
5,772
|
5,572
|
3,801
|
5,813
|
4,173
|
2,969
|
Bedrijfsresultaat (EBIT)
1 |
5,58
|
5,396
|
3,636
|
5,667
|
4,037
|
2,863
|
Operationele Marge
|
40,52%
|
39,68%
|
33,1%
|
40,68%
|
31,79%
|
26,3%
|
Resultaat voor belastingen (EBT)
1 |
5,466
|
6,03
|
4,161
|
5,878
|
3,228
|
3,251
|
Nettowinst (verlies)
1 |
4,352
|
4,762
|
3,305
|
4,659
|
2,57
|
2,581
|
Nettomarge
|
31,61%
|
35,01%
|
30,08%
|
33,44%
|
20,23%
|
23,71%
|
WPA
2 |
0,9473
|
1,036
|
0,7194
|
1,014
|
0,5593
|
0,5619
|
Free Cash Flow
1 |
3,438
|
3,275
|
3,053
|
4,142
|
1,549
|
2,218
|
FCF-marge
|
24,97%
|
24,08%
|
27,79%
|
29,74%
|
12,2%
|
20,38%
|
Kasstroomconversie (ebitda)
|
59,56%
|
58,77%
|
80,32%
|
71,25%
|
37,13%
|
74,72%
|
Kasstroomconversie (nettowinst)
|
78,98%
|
68,77%
|
92,39%
|
88,91%
|
60,3%
|
85,94%
|
Dividend per aandeel
2 |
1,050
|
1,100
|
0,7800
|
1,130
|
0,6800
|
0,3500
|
Datum van publicatie
|
21/03/19
|
26/03/20
|
22/03/21
|
23/03/22
|
23/03/23
|
22/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
8,17
|
7,92
|
8,18
|
8,17
|
6,48
|
9,09
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
3,44
|
3,27
|
3,05
|
4,14
|
1,55
|
2,22
|
ROE (netto-inkomsten/eigen vermogen)
|
39%
|
44,2%
|
31,5%
|
46,2%
|
26,9%
|
25%
|
ROA (netto-inkomsten/totale activa)
|
27,5%
|
27,1%
|
18,7%
|
29,3%
|
22,1%
|
15,2%
|
Totale activa
1 |
15,85
|
17,58
|
17,66
|
15,89
|
11,65
|
17
|
Nettoactief per aandeel
2 |
2,380
|
2,310
|
2,250
|
2,140
|
2,020
|
2,480
|
Cashflow per aandeel
2 |
0,1200
|
0,2300
|
0,1300
|
0,1200
|
0,1800
|
1,790
|
Capex
1 |
0,07
|
0,11
|
0,04
|
0,12
|
0,08
|
0,17
|
Capex/omzet
|
0,54%
|
0,84%
|
0,39%
|
0,84%
|
0,59%
|
1,52%
|
Datum van publicatie
|
21/03/19
|
26/03/20
|
22/03/21
|
23/03/22
|
23/03/23
|
22/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +25,69% | 42,04 mln. | | +31,06% | 682 mld. | | +30,35% | 586 mld. | | -3,42% | 364 mld. | | +18,02% | 327 mld. | | +4,27% | 285 mld. | | +15,53% | 240 mld. | | +10,16% | 209 mld. | | -8,14% | 203 mld. | | +8,12% | 165 mld. |
Farmaceutische producten - Andere
|